Hoggar

Hoggar is an over‑the‑counter oral medication that contains the active ingredient doxylamine hydrogen succinate. It is marketed in the European Union as a first‑generation antihistamine and sleep aid. The product is supplied in tablet (or capsule) form, with a strength that is not publicly disclosed. Doxylamine hydrogen succinate works by blocking peripheral H1 histamine receptors and has anticholinergic properties that produce sedation and promote sleep onset.

Hoggar is commonly used for short‑term relief of several conditions related to histamine activity.

- Insomnia (difficulty falling or staying asleep). - Allergic rhinitis symptoms such as sneezing, runny nose, and itchy eyes. - Relief of minor symptoms associated with the common cold, including nasal congestion and watery eyes. - As a short‑acting antihistamine to manage occasional allergy flare‑ups.

Like other first‑generation antihistamines, doxylamine may cause a range of adverse effects, most of which are mild and transient.

Common: - Drowsiness or sedation. - Dry mouth. - Dizziness.

Serious: - Severe allergic reaction (rash, swelling, breathing difficulty). - Cardiac arrhythmias. - Confusion or hallucinations.

When considering Hoggar, several precautionary measures should be reviewed to minimize risk and ensure safe use.

- Avoid use in individuals with known hypersensitivity to doxylamine or other first‑generation antihistamines. - Use caution in patients with asthma, chronic obstructive pulmonary disease, or other respiratory conditions, as anticholinergic effects may thicken secretions. - Do not operate machinery or drive after taking the medication due to possible sedation. - Limit use during pregnancy and breastfeeding; consult a healthcare professional because safety data are limited. - Elderly patients may be more susceptible to confusion, falls, and urinary retention; start with the lowest effective dose. - Patients with glaucoma, enlarged prostate, or urinary outflow obstruction should discuss use with a clinician.

Doxylamine can interact with several medicines, altering its sedative effect or increasing the risk of adverse reactions.

Avoid: - Alcohol or other central nervous system depressants (e.g., benzodiazepines, opioids) because combined sedation can be profound. - Monoamine oxidase inhibitors (MAOIs) or within 14 days of discontinuation, due to risk of hypertensive reactions. - Other antihistamines or anticholinergic agents, which may amplify anticholinergic burden.

Use with caution: - Sedating antidepressants (e.g., trazodone, mirtazapine) – monitor for excessive drowsiness. - Anticholinergic drugs such as diphenhydramine, atropine – watch for dry mouth, urinary retention. - CYP2D6 substrates (e.g., codeine, tramadol) – doxylamine may inhibit metabolism, increasing plasma levels.